Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of Erythropoiesis
Anemia of cancer and chronic inflammatory diseases is a frequent complication affecting quality of life. For cancer patients it represents a particularly bad prognostic. Low level of erythropoietin is considered as one of the causes of anemia in these pathologies. The deficiency in erythropoietin pr...
Saved in:
Main Authors: | F. Morceau (Author), M. Dicato (Author), M. Diederich (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
by: Patrick Biggar, et al.
Published: (2017) -
Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019) -
Erythropoiesis: insights into pathophysiology and treatments in 2017
by: Andrea Zivot, et al.
Published: (2018) -
Erythropoietin: from erythropoiesis to cardioprotection
by: Liermis Michael Dita Salabert, et al.
Published: (2010) -
Erythropoietin: from erythropoiesis to cardioprotection
by: Liermis Michael Dita Salabert, et al.
Published: (2010)